Article Details

Infliximab attenuates COVID-19 antibody response

Retrieved on: 2021-03-29 10:41:15

Tags for this article:

Click the tags to see associated articles and topics

Infliximab attenuates COVID-19 antibody response. View article details on hiswai:

Excerpt

... compared antibody responses in those treated with either infliximab or vedolizumab, a gut selective anti-integrin alpha4beta7 monoclonal antibody, ...

Article found on: hospitalhealthcare.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo